AcelRx Pharmaceuticals (ACRX) has its PDUFA date the day before
on the 12th. Its compound ARX-04 is up for approval to treat
moderate-to-severe acute pain following a surgical procedure.
This is a crowded space and there are much more diverse views on
whether this compound will be approved. I don't own or have
opinion on this name, but stock is likely to be very volatile this
week depending on which way the decision goes due to the greater
uncertainty.
Small Bull Flags on Daily to Monitor
Posted by steve on 9th of Oct 2017 at 09:27 am
ACRX MAS MU VYGR FENG
from seekingalpha
Posted by zhuma777 on 9th of Oct 2017 at 11:02 am
AcelRx Pharmaceuticals (ACRX) has its PDUFA date the day before on the 12th. Its compound ARX-04 is up for approval to treat moderate-to-severe acute pain following a surgical procedure. This is a crowded space and there are much more diverse views on whether this compound will be approved. I don't own or have opinion on this name, but stock is likely to be very volatile this week depending on which way the decision goes due to the greater uncertainty.
Thanks zhuma for sharing...that's quite
Posted by steve on 9th of Oct 2017 at 11:09 am
Thanks zhuma for sharing...that's quite relevant if trading this name